Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2010-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejpb.2010.01.011PMID 20102737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of an oral rutin nanocrystal formulation.

  2009cited by this paper
• Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.

  2009cited by this paper
• Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.

  2009cited by this paper
• Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery

  2009cited by this paper
• Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.

  2008cited by this paper
• Nebulization of nanoparticulate amorphous or crystalline tacrolimus--single-dose pharmacokinetics study in mice.

  2008cited by this paper
• Inhaled nanoparticles--a current review.

  2008cited by this paper
• Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.

  2008cited by this paper
• Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution.

  2008cited by this paper
• High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.

  2008cited by this paper
• Hot-melt extrusion for enhanced delivery of drug particles.

  2007cited by this paper
• Inhaling medicines: delivering drugs to the body through the lungs

  2007cited by this paper
• Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

  2007cited by this paper
• Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.

  2007cited by this paper
• Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media.

  2007cited by this paper
• Particle Engineering for Pulmonary Drug Delivery

  2007cited by this paper
• Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.

  2007cited by this paper
• Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.

  2007cited by this paper
• Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in‐vitro characterization, ex‐vivo and in‐vivo studies

  2007cited by this paper
• Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.

  2006cited by this paper
• Targeted High Lung Concentrations of Itraconazole Using Nebulized Dispersions in a Murine Model

  2006cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• Single dose and multiple dose studies of itraconazole nanoparticles.

  2006cited by this paper
• In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis

  2006cited by this paper
• Inhalation aerosols : physical and biological basis for therapy

  2006cited by this paper
• Novel sustained release microspheres for pulmonary drug delivery.

  2005cited by this paper
• A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.

  2005cited by this paper
• Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages.

  2005cited by this paper
• The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers

  2004cited by this paper
• Physics of amorphous solids.

  2004cited by this paper
• Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.

  2004cited by this paper
• The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.

  2004cited by this paper
• Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion

  2004cited by this paper
• Lyophilization of polyethylene glycol mixtures.

  2004cited by this paper
• Nanosuspensions: a promising drug delivery strategy

  2004cited by this paper
• Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.

  2003cited by this paper
• Pulmonary drug delivery systems: recent developments and prospects.

  2002cited by this paper
• Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

  2002cited by this paper
• Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.

  2002cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster.

  2001cited by this paper
• Improving drug solubility for oral delivery using solid dispersions.

  2000cited by this paper
• What is the True Solubility Advantage for Amorphous Pharmaceuticals?

  2000cited by this paper
• Water-insoluble drug formulation

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Characteristics and significance of the amorphous state in pharmaceutical systems.

  1997cited by this paper
• Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.

  1996cited by this paper
• Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

  1995cited by this paper
• Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques

  1995cited by this paper
• Deposition Patterns of Aerosolized Drugs Within Human Lungs: Effects of Ventilatory Parameters

  1993cited by this paper
• Intrapulmonary deposition of aerosolized Evans blue dye and liposomes in an experimental porcine model of early ARDS.

  1990cited by this paper
• The effect of particle size distribution on dissolution rate and oral absorption

  1989cited by this paper
• Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of an antimalarial drug.

  1976cited by this paper
• Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid.

  1969cited by this paper
• Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.

  1967cited by this paper

• Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles

  2025cites this paper
• Self-assembly supramolecular ternary co-crystal systems containing Glibenclamide: physicochemical and Pharmacodynamic studies

  2025cites this paper
• Evaluation of modifier type (mineral or organic) and modifier location (top layer or sublayer) on fouling mitigation in MMM and TFC membranes

  2025cites this paper
• Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy.

  2025cites this paper
• Recent developments in the use of nanocrystals to improve bioavailability of APIs.

  2024cites this paper
• Enhanced oral bioavailability of megestrol acetate via polymer-hybridized solid lipid nanoparticles using ultrasonic nebulization method

  2024cites this paper
• Recent advances in nanocrystal-based technologies applied for ocular drug delivery

  2024cites this paper
• Intestinal distribution of anionic, cationic, and neutral polymer-stabilized nanocarriers measured with a lanthanide (europium) tracer assay.

  2024cites this paper
• A Comparative Pharmacokinetics Study of Orally and Intranasally Administered 8-Nitro-1,3-benzothiazin-4-one (BTZ043) Amorphous Drug Nanoparticles

  2024cites this paper
• A Comprehensive Review on Nanoplex Nanotechnology Strategies

  2024cites this paper
• The Solubility Studies and the Complexation Mechanism Investigations of Biologically Active Spiro[cyclopropane-1,3′-oxindoles] with β-Cyclodextrins

  2023cites this paper
• Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders

  2023cites this paper
• Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid–base neutralization approach

  2023cites this paper
• Formulation Strategies of Nanosuspensions for Various Administration Routes

  2023cites this paper
• Nanocrystals based pulmonary inhalation delivery system: advance and challenge

  2022cites this paper
• Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections

  2022cites this paper
• High dose nanocrystalline solid dispersion powder of voriconazole for inhalation.

  2022cites this paper
• Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability

  2022cites this paper
• The antisolvent coprecipitation method for enhanced bioavailability of poorly water-soluble drugs.

  2022cites this paper
• Impact of Excipients and Seeding on the Solid-State Form Transformation of Indomethacin during Liquid Antisolvent Precipitation

  2022cites this paper
• Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects

  2021cites this paper
• Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.

  2021cites this paper
• A silicon-made microfluidic device for the fabrication of excipient-free pure drug nanoparticles

  2021cites this paper
• Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency

  2021cites this paper
• Nanocrystallization and Nanoprecipitation Technologies

  2021cites this paper
• Sea urchin-like calcium borate microspheres and synergistic action with cholinesterase-inhibiting insecticides for ecofriendly Spodoptera littoralis control.

  2021cites this paper
• Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing

  2021cites this paper
• Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections.

  2021cites this paper
• Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.

  2021cites this paper
• Hot stage microscopy and its applications in pharmaceutical characterization

  2020cites this paper
• Degrees of order: a comparison of nanocrystal and amorphous solids for poorly soluble drugs.

  2020cites this paper
• Intramacrophage delivery of dual drug loaded nanoparticles for effective clearance of Mycobacterium tuberculosis.

  2020cites this paper
• Fabrication of advanced parenteral drug-delivery systems

  2020cites this paper
• Inhalable microparticles containing terbinafine for management of pulmonary fungal infections: Spray drying process engineering using lactose vs. mannitol as excipients

  2020cites this paper
• Pharmacokinetics behaviors of l-menthol after inhalation and intravenous injection in rats and its inhibition effects on CYP450 enzymes in rat liver microsomes

  2019cites this paper
• Fluticasone propionate nanosuspensions for sustained nebulization delivery: An in vitro and in vivo evaluation.

  2019cites this paper
• Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: in-vitro characterization, PAMPA and in-vivo assessment.

  2019cites this paper
• Administration Routes for Nano Drugs and Characterization of Nano Drug Loading

  2019cites this paper
• State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation

  2019cites this paper
• Novel strategy for improving the bioavailability of curcumin based on a new membrane transport mechanism that directly involves solid particles

  2018cites this paper
• Nanocrystals of poorly soluble drugs : 2 drug bioavailability and physicochemical stability 3

  2018cites this paper
• Morphological and Physicochemical Evaluation of Two Distinct Glibenclamide/Hypromellose Amorphous Nanoparticles Prepared by the Antisolvent Method.

  2018cites this paper
• Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.

  2018cites this paper
• Process optimization of spray-dried fanhuncaoin powder for pulmonary drug delivery and its pharmacokinetic evaluation in rats

  2018cites this paper
• Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability

  2018cites this paper
• Drug nanocrystals for cancer therapy.

  2018cites this paper
• Therapeutics Applications of Nanosuspension in Topical/ Mucosal Drug Delivery

  2018cites this paper
• Dry powder inhaler formulations of poorly water‐soluble itraconazole: A balance between in‐vitro dissolution and in‐vivo distribution is necessary

  2018cites this paper
• In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice

  2017cites this paper
• Hyaluronidase: A Potential New Treatment for Acute Respiratory DistressSyndrome

  2017cites this paper
• Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.

  2017cites this paper
• Enhanced transmucosal delivery of itraconazole by thiolated d‐&agr;‐tocopheryl poly(ethylene glycol) 1000 succinate micelles for the treatment of Candida albicans

  2017cites this paper
• Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions

  2017cites this paper
• Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus® processed by hot melt extrusion.

  2017cites this paper
• Olfactory transport efficiency of the amorphous and crystalline manganese oxide nanoparticles

  2017cites this paper
• Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.

  2017cites this paper
• Pharmaceutical Amorphous Nanoparticles.

  2017cites this paper
• A stable hydrocortisone nanosuspension for improved dissolution: Preparation, characterization and in vitro evaluation.

  2017cites this paper
• Assessment of nanocomposites vs. amorphous solid dispersions for dissolution enhancement of bcs class ii drugs

  2017cites this paper
• Xanthoceraside hollow gold nanoparticles, green pharmaceutics preparation for poorly water-soluble natural anti-AD medicine.

  2016cites this paper
• Small is big: Is Nanoamorphous Better than Amorphous Solid Dispersion and Nanocrystalline in Pharma?

  2016cites this paper
• Polymer-drug nanoconjugate – an innovative nanomedicine: challenges and recent advancements in rational formulation design for effective delivery of poorly soluble drugs.

  2016cites this paper
• Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer

  2016cites this paper
• Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement

  2016cites this paper
• Nanoparticulate Systems for Dental Drug Delivery

  2016cites this paper
• Current Development in the Evaluation Methods of Pulmonary Drug Delivery System

  2016cites this paper
• Synthesis of rough-surface carriers for dry powder inhalation

  2016cites this paper
• Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.

  2016cites this paper
• Nanotechnology for Pulmonary and Nasal Drug Delivery

  2016cites this paper
• Influence of Disorder on Dissolution

  2016cites this paper
• Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.

  2016cites this paper
• Pre-formulation Study of Salicylidine-cephalexin-Zn(II) dihydrate, a New Derivative of Cefalexin

  2016cites this paper
• A Review of Polymorphism and the Amorphous State in the Formulation Strategy of Medicines and Marketed Drugs

  2015cites this paper
• NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols

  2015influential citation
• Inhaled formulations and pulmonary drug delivery systems for respiratory infections.

  2015cites this paper
• Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.

  2015cites this paper
• Dry Powder Inhalation for Pulmonary Delivery: Recent Advances and Continuing Challenges

  2015cites this paper
• Micronisation of Pharmaceuticals Using Dense Gas Based Microfluidic Processes

  2015cites this paper
• Direct evaluation of molecular States of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopies.

  2015cites this paper
• Study of the Preparation of Amorphous Itraconazole Formulations

  2015cites this paper
• Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension

  2015cites this paper
• Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration

  2015cites this paper
• A review of nanotechnology with an emphasis on Nanoplex

  2015cites this paper
• Coamorphous Lurasidone Hydrochloride−Saccharin with Charge- Assisted Hydrogen Bonding Interaction Shows Improved Physical Stability and Enhanced Dissolution with pH-Independent Solubility Behavior

  2015cites this paper
• Formulation Strategies for Pulmonary Delivery of Poorly Soluble Drugs

  2015cites this paper
• Understanding pharmaceutical polymorphic transformations II: crystallization variables and influence on dosage forms.

  2015cites this paper
• Effect of processing parameters on the physicochemical and aerodynamic properties of respirable brittle matrix powders

  2014cites this paper
• Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

  2014cites this paper
• Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.

  2014cites this paper
• Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.

  2014influential citation
• In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by Thin Film Freezing and Micronization

  2014cites this paper
• Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.

  2014cites this paper
• Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole.

  2014cites this paper
• The impact of pulmonary diseases on the fate of inhaled medicines--a review.

  2014cites this paper
• Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.

  2014cites this paper
• Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis

  2014cites this paper
• Preparation and characterization of fast dissolving pullulan films containing griseofulvin nanoparticles for bioavailability enhancement

  2014cites this paper
• Measurement of the size and charge distribution of sodium chloride particles generated by an Aeroneb Pro® pharmaceutical nebulizer

  2014cites this paper
• Phospholipids in pulmonary drug delivery

  2014cites this paper
• Effect of Spray Drying Conditions on the Physicochemical Properties and Enthalpy Relaxation of α-Lactose

  2014cites this paper